Neumora Therapeutics Overview
Neumora Therapeutics Discounted Cash Flow
DCF Analysis for NMRA.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.11
Current Fair Value
$1.11
↓ 37.4% Downside
Overvalued by 37.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison